We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+1.12%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$28.3B
AUM Growth
-$930M
Cap. Flow
-$234M
Cap. Flow %
-0.83%
Top 10 Hldgs %
43.26%
Holding
1,183
New
46
Increased
601
Reduced
483
Closed
43

Sector Composition

Rank Sector Weight
1 Technology 41.4%
2 Financials 10.42%
3 Consumer Discretionary 7.12%
4 Healthcare 4.51%
5 Industrials 2.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLF icon
1126
Cleveland-Cliffs
CLF
$6.57B
$104K ﹤0.01%
11,055
+263
+2% +$3.17K
JOBY icon
1127
Joby Aviation
JOBY
$7.03B
$96.2K ﹤0.01%
11,827
+1,158
+11% +$7.68K
PHAT icon
1128
Phathom Pharmaceuticals
PHAT
$708M
$90.2K ﹤0.01%
+11,113
New +$138K
CHPT icon
1129
ChargePoint
CHPT
$141M
$83.2K ﹤0.01%
3,887
-839
-18% -$20.8K
EYPT icon
1130
EyePoint Inc
EYPT
$1.03B
$81.8K ﹤0.01%
10,980
-465
-4% -$4.33K
ESPR
1131
DELISTED
Esperion Therapeutics
ESPR
$81.5K ﹤0.01%
+37,056
New +$86.5K
PSNY icon
1132
Polestar Automotive Holding UK
PSNY
$2.09B
$81K ﹤0.01%
2,572
-5,557
-68% -$201K
QS icon
1133
QuantumScape Corp
QS
$3.21B
$80.7K ﹤0.01%
15,549
-8,903
-36% -$46.7K
ARKO icon
1134
ARKO Corp
ARKO
$896M
$69.1K ﹤0.01%
10,493
-4,351
-29% -$30K
WULF icon
1135
TeraWulf
WULF
$8.75B
$69.1K ﹤0.01%
+12,202
New +$78.7K
NUVB icon
1136
Nuvation Bio
NUVB
$2.2B
$64.7K ﹤0.01%
24,327
-2,324
-9% -$5.98K
XERS icon
1137
Xeris Biopharma Holdings
XERS
$1.39B
$60.1K ﹤0.01%
17,720
-1,392
-7% -$4.48K
CIFR icon
1138
Cipher Digital
CIFR
$9.13B
$48.7K ﹤0.01%
+10,490
New +$59.5K
NKLA
1139
DELISTED
Nikola Corporation Common Stock
NKLA
$28.5K ﹤0.01%
23,950
+5,143
+27% +$14.7K
KEEL
1140
Keel Infrastructure Corp
KEEL
$2.4B
$21.6K ﹤0.01%
+14,464
New +$28.9K
ALEC icon
1141
Alector
ALEC
$168M
-72,750
Closed -$339K
AMPH icon
1142
Amphastar Pharmaceuticals
AMPH
$879M
-5,714
Closed -$277K
APLT
1143
DELISTED
Applied Therapeutics
APLT
-159,262
Closed -$1.35M
ARVN icon
1144
Arvinas
ARVN
$518M
-12,896
Closed -$318K
CATX icon
1145
Perspective Therapeutics
CATX
$332M
-101,138
Closed -$1.35M
CCCC icon
1146
C4 Therapeutics
CCCC
$385M
-143,855
Closed -$820K
CHE icon
1147
Chemed
CHE
$7.07B
-347
Closed -$209K
COLL icon
1148
Collegium Pharmaceutical
COLL
$1.15B
-6,225
Closed -$241K
CRBP icon
1149
Corbus Pharmaceuticals
CRBP
$166M
-34,039
Closed -$702K
DCI icon
1150
Donaldson
DCI
$10.9B
-2,776
Closed -$205K

Similar funds

Rafferty Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Rafferty Asset Management held 1,183 positions worth $28.3B, down 3.2% from $29.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Rafferty Asset Management's Q4 2024 filing shows 46 new, 601 increased, 483 reduced and 43 closed positions. Its largest new stake was Apollo Global Management: 157,705 shares worth $26M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $495M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 45% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Rafferty Asset Management's largest Q4 2024 buy was Apollo Global Management: 157,705 shares worth $26M.
  • Rafferty Asset Management added most to Tesla in Q4 2024, an estimated $338M increase.
  • Rafferty Asset Management's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $495M.
  • Rafferty Asset Management fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $9.52M.
  • Rafferty Asset Management's ten largest holdings make up 43% of its $28.3B portfolio in Q4 2024.
  • Rafferty Asset Management opened 46 new positions and closed 43 in Q4 2024.
  • Rafferty Asset Management's portfolio value fell 3.2% quarter-over-quarter to $28.3B.

Based on Rafferty Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.